Max Robotics — Global Service Robot Directory + US Certification

About

Stefano Schena is a leading cardiac surgeon and researcher specializing in the treatment of complex atrial fibrillation, particularly persistent and long-standing persistent forms. His work centers on advancing hybrid ablation techniques, with a major focus on robotic-enhanced epicardial ablation (RE-EA) as part of a staged, minimally invasive approach. Schena’s key contributions include demonstrating the feasibility, safety, and early efficacy of robotic-enhanced hybrid ablation (RE-HA), and identifying biophysical predictors—such as functional conduction gaps and atrial fibrosis—that influence early arrhythmia recurrence. His 2024 study on robotic-enhanced hybrid ablation for persistent atrial fibrillation has already garnered 11 citations, underscoring its impact on the field. By integrating epicardial and endocardial ablation with robotic precision, Schena is helping to refine patient selection and procedural strategies for those with challenging arrhythmias. His ongoing work promises to improve long-term outcomes and reduce recurrence, positioning him as a key innovator in the surgical management of atrial fibrillation.